These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 14977967)

  • 1. Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.
    Taylor DW; Zhou A; Marsillio LE; Thuita LW; Leke EB; Branch O; Gowda DC; Long C; Leke RF
    Infect Immun; 2004 Mar; 72(3):1603-7. PubMed ID: 14977967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates.
    Khattab A; Reinhardt C; Staalsoe T; Fievet N; Kremsner PG; Deloron P; Hviid L; Klinkert MQ
    Malar J; 2004 Jul; 3():21. PubMed ID: 15242514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.
    Tutterrow YL; Avril M; Singh K; Long CA; Leke RJ; Sama G; Salanti A; Smith JD; Leke RG; Taylor DW
    Infect Immun; 2012 Apr; 80(4):1479-90. PubMed ID: 22331427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
    Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
    Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequestration of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal pan-reactive epitopes in placental isolates.
    Lekana Douki JB; Traore B; Costa FT; Fusaï T; Pouvelle B; Sterkers Y; Scherf A; Gysin J
    Blood; 2002 Aug; 100(4):1478-83. PubMed ID: 12149234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.
    Beeson JG; Mann EJ; Byrne TJ; Caragounis A; Elliott SR; Brown GV; Rogerson SJ
    J Infect Dis; 2006 Mar; 193(5):721-30. PubMed ID: 16453269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
    Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW
    PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A.
    Ricke CH; Staalsoe T; Koram K; Akanmori BD; Riley EM; Theander TG; Hviid L
    J Immunol; 2000 Sep; 165(6):3309-16. PubMed ID: 10975848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of VAR2CSA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line.
    Yosaatmadja F; Andrews KT; Duffy MF; Brown GV; Beeson JG; Rogerson SJ
    Malar J; 2008 Mar; 7():51. PubMed ID: 18364051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
    Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
    Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia.
    Staalsoe T; Megnekou R; Fievét N; Ricke CH; Zornig HD; Leke R; Taylor DW; Deloron P; Hviid L
    J Infect Dis; 2001 Sep; 184(5):618-26. PubMed ID: 11494167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta.
    Rovira-Vallbona E; Monteiro I; Bardají A; Serra-Casas E; Neafsey DE; Quelhas D; Valim C; Alonso P; Dobaño C; Ordi J; Menéndez C; Mayor A
    PLoS One; 2013; 8(7):e69753. PubMed ID: 23936092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin.
    Ndam NT; Denoeud-Ndam L; Doritchamou J; Viwami F; Salanti A; Nielsen MA; Fievet N; Massougbodji A; Luty AJ; Deloron P
    Emerg Infect Dis; 2015 May; 21(5):813-23. PubMed ID: 25898123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
    Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
    J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens.
    Siriwardhana C; Fang R; Salanti A; Leke RGF; Bobbili N; Taylor DW; Chen JJ
    Malar J; 2017 Sep; 16(1):391. PubMed ID: 28962616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A.
    Gysin J; Pouvelle B; Fievet N; Scherf A; Lépolard C
    Infect Immun; 1999 Dec; 67(12):6596-602. PubMed ID: 10569780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae.
    Cox SE; Staalsoe T; Arthur P; Bulmer JN; Hviid L; Yeboah-Antwi K; Kirkwood BR; Riley EM
    Infect Immun; 2005 May; 73(5):2841-7. PubMed ID: 15845489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy.
    Fievet N; Le Hesran JY; Cottrell G; Doucoure S; Diouf I; Ndiaye JL; Bertin G; Gaye O; Sow S; Deloron P
    Infect Genet Evol; 2006 Nov; 6(6):459-63. PubMed ID: 16621725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.
    Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L
    Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M; Duffy PE
    Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.